• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. BIOGLUE - UNKNOWN CONFIGURATION; GLUE,SURGICAL,ARTERIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. BIOGLUE - UNKNOWN CONFIGURATION; GLUE,SURGICAL,ARTERIES Back to Search Results
Model Number BG UNK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Cerebrospinal Fluid Leakage (1772)
Event Type  Injury  
Event Description
According to the initial report received, "the patients underwent endoscopic pituitary surgery where bioglue was used as an adjunct to sellar/skull base repair.¿in 50 patients, 1 (2%) suffered a post-operative csf leak.There were no instances of post-operative meningitis.In total, 1/50 (2%) patient was treated with oral antibiotics by their general practitioner for presumed sinusitis 2 weeks post-operatively.None of the patients has required rhinological intervention/surgery during the follow-up period (median 24 months, range 11¿41).¿.
 
Event Description
Additional information was received from the author: i don't have the lot number.It may possibly be in the patient's medical records.However, the following points may be useful for you: the purpose of this paper & its message is that despite previously published concerns we found that bioglue did not cause an inflammatory reaction & did not increase infection rate, when used in transnasal / transsphenoidal operations.We reported the postoperative csf leak rate in this group of patient but it wasn't the main subject of this paper.We are preparing further papers on that.Bioglue does not result in csf leak.Csf leak is a well known postoperative complication of transnasal surgery for pituitary tumours & skull base tumours.The rate of postoperative csf leak depends on several factors but most importantly the pathology of the tumour being removed, the extent of bony and dural defect being repaired, the method of repair & the experience of the surgeon.For example extended approaches particularly for certain types of tumour such as meningioma & craniopharyngioma have a high incidence of postop csf leak.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOGLUE - UNKNOWN CONFIGURATION
Type of Device
GLUE,SURGICAL,ARTERIES
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer (Section G)
CRYOLIFE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer Contact
rochelle maney maney
1655 roberts blvd. nw
kennesaw, GA 30144
7704193355
MDR Report Key14547956
MDR Text Key292975942
Report Number1063481-2022-00008
Device Sequence Number1
Product Code MUQ
Combination Product (y/n)N
Reporter Country CodeEI
PMA/PMN Number
P010003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberBG UNK
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/04/2022
Initial Date FDA Received05/31/2022
Supplement Dates Manufacturer Received05/04/2022
Supplement Dates FDA Received07/18/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-